First Week of MBLY March 27th Options Trading

Stock Options Channel outlines option-income setups for Mobileye (MBLY) with the stock trading at $8.60. Selling a $8.50 put (bid $0.36) nets a $8.14 effective purchase basis, is ~1% OTM, has a modeled 57% chance to expire worthless and implies a 4.24% cash-return (31.58% annualized) YieldBoost; selling a $9.50 covered call (bid $0.20) against shares bought at $8.60 yields 12.79% if called by the March 27 expiration, is ~10% OTM, has a 61% chance to expire worthless and implies a 2.33% (17.34% annualized) YieldBoost. Implied vols are ~63% (put) and 66% (call) versus a 12-month trailing volatility of 58%.

Analysis

Market structure: The immediate winners are option premium sellers and income-focused holders — selling the $8.50 put (collect $0.36) or the $9.50 covered call ($0.20) converts volatility into ~4.24% or ~2.33% one-cycle yield (31.6% and 17.3% annualized). Direct losers are pure upside-seekers who would be capped at $9.50 and option buyers if realized volatility remains below current IV (63–66% vs realized 58%). The activity signals modest demand for ownership at sub-$9 levels and a market pricing that favors yield over directional conviction for the near-term March 27 expiry.

Risk assessment: Tail risks include an adverse ADAS regulatory event, supply-chain shock (chip shortage) or a negative sell-side technological update that could gap MBLY >30% — assignment risk is non-trivial for cash-secured puts. Time horizon: immediate (days) risk is IV and liquidity; short-term (weeks to March 27) is option theta decay; long-term (quarters) depends on ADAS adoption and OEM contracts. Hidden dependencies include wide options bid-ask, potential early assignment around corporate announcements, and correlation to semiconductor moves (NVDA, SOXX) which can amplify moves.

Trade implications: Direct, low-beta play: establish small, cash-secured put exposure via sell-to-open MBLY $8.50 Mar27 at $0.36 sized to 1–3% NAV to target a $8.14 basis if assigned. If already long, sell the $9.50 Mar27 covered call at $0.20 to generate 2.33% one-cycle yield, roll up/extend if price >$10.50. If directional and expecting a >15% move into/through expiry, consider buying a long-call spread or straddle only if you expect realized vol to exceed IV by >5 pts before expiry.

Contrarian angles: The market may be understating idiosyncratic upside (OEM design wins or M&A chatter) because IV is only marginally above realized (63% vs 58%), so one can harvest premium now and be ready to switch to long-delta if a positive catalyst appears. Conversely, option sellers may be complacent: a single negative OEM announcement could move MBLY >25% and turn attractive annualized yields into immediate mark-to-market losses. Historical parallel: ADAS/semiconductor micro-cycles show fast reversals; limit position sizes and pre-define roll/assignment rules.

Key Decisions for Investors

• Sell cash-secured MBLY $8.50 puts expiring March 27 at $0.36: position size 1–3% of portfolio (notional), target effective entry if assigned $8.14/share, max cash commitment = $8.50 * contracts; close or roll if MBLY < $7.30 (≈15% drawdown) or if IV increases >10 implied vol points.
• If you already own MBLY shares, sell covered calls MBLY $9.50 Mar27 at $0.20 to pocket 2.33% one-cycle yield; if price > $10.50 before expiry, roll up-and-out to preserve upside (move to $11.50 one month further) or buy back at target loss 50% of premium.
• Do a volatility pair: buy a near-term MBLY long-call spread (buy $9.50, sell $12.50) only if you see IV compress <55% and put-call skew steepens; allocate ≤0.5% NAV and target >2x return if MBLY > $11 by expiry.
• Avoid directional size >3% NAV long MBLY until post-earnings/OEM-announcement; instead harvest premium and convert to long equity only after a confirmed positive catalyst (e.g., incremental OEM win or M&A signal) that lifts IV by >10 pts within 30 days.